加快药品审评的用户付费。它们对公众健康是有帮助还是有损害？ - Suppr

Suppr

超能文献

User fees for faster drug reviews. Are they helping or hurting the public health?

作者信息

Thompson L

出版信息

FDA Consum. 2000 Sep-Oct;34(5):25-9.

PMID:11590789

Abstract

摘要

相似文献

User fees for faster drug reviews. Are they helping or hurting the public health?

FDA Consum. 2000 Sep-Oct;34(5):25-9.

The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?

Food Drug Law J. 2005;60(2):261-338.

Paying for drug approvals--who's using whom?

N Engl J Med. 2007 Apr 26;356(17):1697-700. doi: 10.1056/NEJMp078041. Epub 2007 Apr 13.

User fees to fund faster reviews.

FDA Consum. 1993 Oct;27(8):19-21.

New drug law to speed scientific review.

Nature. 1992 Oct 15;359(6396):563. doi: 10.1038/359563a0.

The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.

Healthspan. 1992 Dec;9(11):12-4.

Drug safety reform at the FDA--pendulum swing or systematic improvement?

N Engl J Med. 2007 Apr 26;356(17):1700-2. doi: 10.1056/NEJMp078057. Epub 2007 Apr 13.

PDUFA reauthorization--drug safety's golden moment of opportunity?

N Engl J Med. 2007 Apr 26;356(17):1703-4. doi: 10.1056/NEJMp078048. Epub 2007 Apr 13.

User fees to hasten FDA review.

Nature. 1992 Oct 15;359(6396):567. doi: 10.1038/359567b0.

A critical tipping point.

US News World Rep. 2002 Apr 22;132(13):72.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

User fees for faster drug reviews. Are they helping or hurting the public health?

FDA Consum. 2000 Sep-Oct;34(5):25-9.

The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?

Food Drug Law J. 2005;60(2):261-338.

Paying for drug approvals--who's using whom?

N Engl J Med. 2007 Apr 26;356(17):1697-700. doi: 10.1056/NEJMp078041. Epub 2007 Apr 13.

User fees to fund faster reviews.

FDA Consum. 1993 Oct;27(8):19-21.

New drug law to speed scientific review.

Nature. 1992 Oct 15;359(6396):563. doi: 10.1038/359563a0.

The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.

Healthspan. 1992 Dec;9(11):12-4.

Drug safety reform at the FDA--pendulum swing or systematic improvement?

N Engl J Med. 2007 Apr 26;356(17):1700-2. doi: 10.1056/NEJMp078057. Epub 2007 Apr 13.

PDUFA reauthorization--drug safety's golden moment of opportunity?

N Engl J Med. 2007 Apr 26;356(17):1703-4. doi: 10.1056/NEJMp078048. Epub 2007 Apr 13.

User fees to hasten FDA review.

Nature. 1992 Oct 15;359(6396):567. doi: 10.1038/359567b0.

A critical tipping point.

US News World Rep. 2002 Apr 22;132(13):72.